Informationen:
Fehler:
ID
13246
Beschreibung
Clofarabine Pre-conditioning With Allogeneic Transplant for Acute Myeloid Leukaemia (AML); ODM derived from: https://clinicaltrials.gov/show/NCT01422603
Link
https://clinicaltrials.gov/show/NCT01422603
Stichworte
Versionen (1)
- 26.01.16 26.01.16 -
Rechteinhaber
CC BY-NC 3.0
Hochgeladen am
26. Januar 2016
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Acute Myeloid Leukaemia NCT01422603
Eligibility Acute Myeloid Leukaemia NCT01422603
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Acute Myeloid Leukaemia NCT01422603
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
AML or MDS
Item
cytologically and immunophenotypically (or immunohistochemically) confirmed diagnosis of high risk aml or mds
boolean
C0023467 (UMLS CUI [1])
C3463824 (UMLS CUI [2])
C3463824 (UMLS CUI [2])
age
Item
minimum age of 18 years
boolean
C0001779 (UMLS CUI [1])
stem cell transplant
Item
eligible for allogeneic stem cell transplant by local institutional guidelines
boolean
C1504389 (UMLS CUI [1])
suitable matched-related/sibling or volunteer unrelated donor
Item
suitable matched-related/sibling or volunteer unrelated donor available, as determined by local institutional guidelines
boolean
C0013018 (UMLS CUI [1])
pregnancy
Item
negative pregnancy test for females of child-bearing potential within 7 days prior to the start of study treatment
boolean
C0032961 (UMLS CUI [1])
contraception
Item
if sexually active, male and female subjects must agree that they will use an effective method of birth control throughout the active study period
boolean
C0700589 (UMLS CUI [1])
informed consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
capable of and willing to comply
Item
capable of and willing to comply with scheduled visits, treatment plan and required laboratory tests
boolean
C1321605 (UMLS CUI [1])
renal and hepatic function
Item
adequate renal and hepatic function
boolean
C0232804 (UMLS CUI [1])
C0232741 (UMLS CUI [2])
C0232741 (UMLS CUI [2])
psychiatric, addictive or any disorder which compromises ability to give truly informed consent for participation in this study
Item
psychiatric, addictive or any disorder which compromises ability to give truly informed consent for participation in this study
boolean
C0021430 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
previous allogeneic bone marrow or peripheral blood stem cell transplant
Item
previous allogeneic bone marrow or peripheral blood stem cell transplant.
boolean
C0005961 (UMLS CUI [1])
C1504389 (UMLS CUI [2])
C1504389 (UMLS CUI [2])
pregnancy or lactation
Item
pregnant or lactating women. all female subjects of child-bearing potential must have a negative pregnancy test within 7 days prior to the start of treatment.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
current active, invasive malignancy
Item
any current active, invasive malignancy excluding aml or mds
boolean
C0006826 (UMLS CUI [1])